Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Meanwell

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
British Medical Journal (Clinical Research Ed.)|February 6, 1988
Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 casesC A Meanwell, K A Kelly, S Wilson, et al.
Radiology|January 1, 1987
Recurrent female pelvic cancer: assessment with transrectal ultrasonographyC A Meanwell, E B Rolfe, G Blackledge, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1985
Assessment of bleomycin, adriamycin and mitomycin-C in the treatment of recurrent cervical cancerC A Meanwell, D M Luesley, G Blackledge, et al.
Cancer Treatment Reports|April 1, 1986
Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancerF G Lawton, T J Perren, D M Luesley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase II studies of ifosfamide alone and in combination in cancer of the cervixG Blackledge, E J Buxton, J J Mould, et al.
Seminars in Oncology|February 1, 1989
The role of ifosfamide in cervical cancerE J Buxton, G Blackledge, J J Mould, et al.
Cancer Treatment Reports|June 1, 1986
Phase II study of ifosfamide in cervical cancerC A Meanwell, J J Mould, G Blackledge, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Phase II studies of bleomycin, ifosfamide and cis-platinum in advanced and recurrent cervical carcinomaE J Buxton, C A Meanwell, J J Mould, et al.
Journal of the National Cancer Institute|March 1, 1989
Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancerE J Buxton, C A Meanwell, C Hilton, et al.
Lancet (London, England)|February 16, 1985
Encephalopathy associated with ifosphamide/mesna therapyC A Meanwell, A E Blake, T N Latief, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Medical Journal (Clinical Research Ed.)|February 6, 1988
Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 casesC A Meanwell, K A Kelly, S Wilson, et al.
Radiology|January 1, 1987
Recurrent female pelvic cancer: assessment with transrectal ultrasonographyC A Meanwell, E B Rolfe, G Blackledge, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1985
Assessment of bleomycin, adriamycin and mitomycin-C in the treatment of recurrent cervical cancerC A Meanwell, D M Luesley, G Blackledge, et al.
Cancer Treatment Reports|April 1, 1986
Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancerF G Lawton, T J Perren, D M Luesley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase II studies of ifosfamide alone and in combination in cancer of the cervixG Blackledge, E J Buxton, J J Mould, et al.
Seminars in Oncology|February 1, 1989
The role of ifosfamide in cervical cancerE J Buxton, G Blackledge, J J Mould, et al.
Cancer Treatment Reports|June 1, 1986
Phase II study of ifosfamide in cervical cancerC A Meanwell, J J Mould, G Blackledge, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Phase II studies of bleomycin, ifosfamide and cis-platinum in advanced and recurrent cervical carcinomaE J Buxton, C A Meanwell, J J Mould, et al.
Journal of the National Cancer Institute|March 1, 1989
Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancerE J Buxton, C A Meanwell, C Hilton, et al.
Lancet (London, England)|February 16, 1985
Encephalopathy associated with ifosphamide/mesna therapyC A Meanwell, A E Blake, T N Latief, et al.
Pageof 2